Cargando…
Use of Physiologically Based Pharmacokinetic Modeling to Predict Human Gut Microbial Conversion of Daidzein to S-Equol
[Image: see text] A physiologically based pharmacokinetic (PBPK) model was developed for daidzein and its metabolite S-equol. Anaerobic in vitro incubations of pooled fecal samples from S-equol producers and nonproducers allowed definition of the kinetic constants. PBPK model-based predictions for t...
Autores principales: | Wang, Qianrui, Spenkelink, Bert, Boonpawa, Rungnapa, Rietjens, Ivonne M.C.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759082/ https://www.ncbi.nlm.nih.gov/pubmed/34855380 http://dx.doi.org/10.1021/acs.jafc.1c03950 |
Ejemplares similares
-
Use of Physiologically Based Kinetic Modeling to Predict Rat Gut Microbial Metabolism of the Isoflavone Daidzein to S‐Equol and Its Consequences for ERα Activation
por: Wang, Qianrui, et al.
Publicado: (2020) -
Physiologically Based Kinetic Modeling-Facilitated Reverse Dosimetry to Predict In Vivo Red Blood Cell Acetylcholinesterase Inhibition Following Exposure to Chlorpyrifos in the Caucasian and Chinese Population
por: Zhao, Shensheng, et al.
Publicado: (2019) -
PBK Model‐Based Prediction of Intestinal Microbial and Host Metabolism of Zearalenone and Consequences for its Estrogenicity
por: Mendez‐Catala, Diana M., et al.
Publicado: (2021) -
Defining in vivo dose‐response curves for kidney DNA adduct formation of aristolochic acid I in rat, mouse and human by an in vitro and physiologically based kinetic modeling approach
por: Abdullah, Rozaini, et al.
Publicado: (2020) -
An in vitromodel to quantify interspecies differences in kinetics for intestinal microbial bioactivation and detoxification of zearalenone
por: Mendez-Catala, Diana M., et al.
Publicado: (2020)